Compare ARL & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARL | OPRX |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Business Services |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.1M | 245.7M |
| IPO Year | N/A | N/A |
| Metric | ARL | OPRX |
|---|---|---|
| Price | $16.21 | $13.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | 1.5K | ★ 264.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.36 | 0.00 |
| Revenue | $49,060,000.00 | ★ $109,506,000.00 |
| Revenue This Year | N/A | $19.77 |
| Revenue Next Year | N/A | $11.33 |
| P/E Ratio | ★ $44.95 | $7,165.40 |
| Revenue Growth | N/A | ★ 24.18 |
| 52 Week Low | $9.43 | $3.99 |
| 52 Week High | $17.00 | $22.25 |
| Indicator | ARL | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 46.22 |
| Support Level | $15.92 | $11.75 |
| Resistance Level | $16.70 | $13.67 |
| Average True Range (ATR) | 0.42 | 0.61 |
| MACD | 0.00 | 0.15 |
| Stochastic Oscillator | 52.48 | 76.35 |
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.